Fresenius

Biosimilar makers split strategies in bid to take on top-selling Humira
Biosimilar makers split strategies in bid to take on top-selling Humira
BioPharma Dive
biosimilars
Humira
AbbVie
rebates
drug pricing
Amgen
Celltrion
Novartis
Boehringer Ingelheim
Biocon
Fresenius
Sandoz
Organon
Coherus
Flag link:
Go or no go? Key FDA decisions for Argenx and Regeneron
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Flag link:
Fresenius’ new CEO starts strategic review as pressure rises
Fresenius’ new CEO starts strategic review as pressure rises
Pharmaphorum
Fresenius
Michael Sen
Pharma CEOs
Flag link:
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fresenius outlines plans to expand extracorporeal care portfolio to hearts, lungs
Fierce Biotech
diabetes
Fresenius
intensive care
extracorporeal care
dialysis
Flag link:
Fresenius to launch a mechanical ventilators alternative in U.S.
Fresenius to launch a mechanical ventilators alternative in U.S.
Mass Device
Fresenius
devices
Novalung
mechanical ventilators
Flag link:
After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes
After Fresenius deal collapse, Akorn inks $74M settlement with investors over data integrity woes
Fierce Pharma
Akorn
Fresenius
Flag link:
Medtech's Biggest Deals in 2019 ... So Far
Medtech's Biggest Deals in 2019 ... So Far
Medical Devices and Diagnostics Industry
devices
M&A
Hill-Rom
Voalte
Abbott Laboratories
Cephea Valve Technologies
ZOLL Medical
TherOx
Stryker
Arrinex
Medtronic
Epix Therapeutics
Guardant Health
Bellwether Bio
Titan Spine
Bosotn Scientific
Vertiflex
Edward Lifesciences
CAS Medical Systems
Fresenius
NxStage
JNJ
Auris Health
Flag link:
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Akorn's CEO bows out after failing last-ditch bid to save Fresenius merger
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Akorn fights to salvage Fresenius deal in appeal to Delaware Supreme Court
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Judge frees Fresenius from buyout, citing 'extensive and recurring' data problems at Akorn
Fierce Pharma
Akorn
Fresenius
M&A
Flag link:
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fresenius' $4.3B buyout of Akorn threatened by data integrity probe
Fierce Pharma
Fresenius
Akorn
drug manufacturing
generics
data integrity
FDA
Flag link:
Fresenius oncology drug plant slammed with new warning letter
Fresenius oncology drug plant slammed with new warning letter
Fierce Pharma
Fresenius
warnings
drug manufacturing
oncology
Flag link:
Fresenius closer and closer to marketing biosimilars
Fresenius closer and closer to marketing biosimilars
GoinPharma
Fresenius
biosimilars
Flag link:
Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
Open plan designs: The good, the bad and the ugly; Fresenius adding 400-plus staffers
Endpoints
open plan offices
Fresenius
hirings
Flag link:
The 10 largest medtech employers – and what their workers really think
The 10 largest medtech employers – and what their workers really think
Medical Design and Outsourcing
devices
employees
Baxter
B. Braun
Boston Scientific
Cardinal Health
Essilor
Fresenius
GE Healthcare
Medtronic
Philips
Stryker
Flag link:
Fresenius closes Merck biosimilar biz purchase
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fresenius
Merck KGaA
biosimilars
M&A
Flag link:
NxStage Medical Acquired by Fresenius for $2 Billion
NxStage Medical Acquired by Fresenius for $2 Billion
TheStreet.com
Fresenius
NxStage Medical
M&A
dialysis
devices
Flag link:
How Trump’s First 100 Days Affected the Healthcare Industry
How Trump’s First 100 Days Affected the Healthcare Industry
Motley Fool
Donald Trump
Express Scripts
Anthem
insurers
Akorn
Fresenius
Flag link:
Fresenius Kabi picks up generic maker Akorn for $4.3B
Fresenius Kabi picks up generic maker Akorn for $4.3B
BioPharma Dive
M&A
generics
Fresenius
Akorn
Flag link:
Big Pharma has become a leader in the fight against the death penalty
Big Pharma has become a leader in the fight against the death penalty
Yahoo/Business Insider
Big Pharma
execution drugs
McKesson
Pfizer
Fresenius
West-Ward Pharmaceuticals
Flag link:

Pages